Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.
Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page
- ChecktodayNo Change Detected
- CheckyesterdayNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe website has been updated to version v2.10.0, adding 6 more interventions/treatments, 5 more study numbers, and noting that the study now has 244 locations, while the previous version v2.9.7 has been removed.SummaryDifference0.2%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.0%
- Check25 days agoChange DetectedThe value of Revision has recently changed from v2.9.5 to v2.9.6. This change represents an update or modification to the content of the web page.SummaryDifference0.0%
- Check30 days agoChange DetectedThe value Revision: v2.9.3 has recently changed to Revision: v2.9.5. This change represents an update in the study record details and information related to a clinical trial for the treatment of breast cancer using pembrolizumab and chemotherapy.SummaryDifference0.0%
- Check31 days agoChange DetectedThe value Revision: v2.9.1 has recently changed to Revision: v2.9.3. This change represents an update in the study record details and outcomes for a clinical trial evaluating the efficacy and safety of pembrolizumab versus placebo in combination with neoadjuvant chemotherapy and adjuvant endocrine therapy for the treatment of early-stage breast cancer.SummaryDifference0.0%
- Check32 days agoChange DetectedDifference35%
Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.